Header Logo

Connection

Sara Tartof to Child

Back to Details
This is a "connection" page, showing publications Sara Tartof has written about Child.
Sara Tartof
Connection Strength
1.255
Child
  1. Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system. Vaccine. 2023 01 09; 41(2):315-322.
    View in: PubMed
    Score: 0.129
  2. Effectiveness Associated With BNT162b2 Vaccine Against Emergency Department and Urgent Care Encounters for Delta and Omicron SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 Years. JAMA Netw Open. 2022 08 01; 5(8):e2225162.
    View in: PubMed
    Score: 0.127
  3. Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 08; 70(40):1415-1419.
    View in: PubMed
    Score: 0.120
  4. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021 10 16; 398(10309):1407-1416.
    View in: PubMed
    Score: 0.120
  5. Antibiotic and antifungal treatment among persons with confirmed coccidioidomycosis - Southern California, 2011. Med Mycol. 2020 Apr 01; 58(3):411-413.
    View in: PubMed
    Score: 0.108
  6. Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years. Pediatr Infect Dis J. 2017 Nov; 36(11):1087-1092.
    View in: PubMed
    Score: 0.091
  7. Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients: A Cohort Study. Ann Intern Med. 2016 05 03; 164(9):593-9.
    View in: PubMed
    Score: 0.082
  8. Incidence of polymerase chain reaction-diagnosed Clostridium difficile in a large high-risk cohort, 2011-2012. Mayo Clin Proc. 2014 Sep; 89(9):1229-38.
    View in: PubMed
    Score: 0.073
  9. Bordetella holmesii bacteremia cases in the United States, April 2010-January 2011. Clin Infect Dis. 2014 Jan; 58(2):e39-43.
    View in: PubMed
    Score: 0.069
  10. Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt. PLoS One. 2013; 8(5):e63605.
    View in: PubMed
    Score: 0.067
  11. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics. 2013 Apr; 131(4):e1047-52.
    View in: PubMed
    Score: 0.066
  12. Factors associated with Group A Streptococcus emm type diversification in a large urban setting in Brazil: a cross-sectional study. BMC Infect Dis. 2010 Nov 11; 10:327.
    View in: PubMed
    Score: 0.056
  13. Inverse association between Lancefield group G Streptococcus colonization and sore throat in slum and nonslum settings in Brazil. J Clin Microbiol. 2011 Jan; 49(1):409-12.
    View in: PubMed
    Score: 0.056
  14. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):365-370.
    View in: PubMed
    Score: 0.031
  15. Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds. Pediatrics. 2017 01; 139(1).
    View in: PubMed
    Score: 0.022
  16. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015 Apr; 11(4):e1004138.
    View in: PubMed
    Score: 0.019
  17. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol. 2014 Dec; 71(12):1506-13.
    View in: PubMed
    Score: 0.019

© 2025 Kaiser Permanente